Pediculosis — Safety and Tolerability of a Novel Malathion Formulation in Children Age 6-24 Months With Head Lice
Citation(s)
Phase II, Multi-Center, Open-Label, Safety and Tolerance Study of a Novel Malathion Formulation in Infants and Toddlers With Pediculosis Capitis